Concepedia

Kate Mostoller

KM

Statistics

Publications

7

Citations

201

H-Index

7

Active since

2013

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Covance (United States)

Kate Mostoller is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, clinical pharmacology, and pharmacokinetics.

Publications per year

2013–2021

7

Publications

7

A Microdose Cocktail to Evaluate Drug Interactions in Patients with Renal Impairment

Daniel Tatosian, Ka Lai Yee, Zufei Zhang et al. · Clinical Pharmacology & Therapeutics · 2020 · 53 citations

, , +12

Preclinical to Human Translational Pharmacology of the Novel M1 Positive Allosteric Modulator MK-7622

Jason M. Uslaner, Scott D. Kuduk, Marion Wittmann et al. · Journal of Pharmacology and Experimental Therapeutics · 2018 · 38 citations · Full text

, , +17

Odanacatib, a Selective Cathepsin K Inhibitor, Demonstrates Comparable Pharmacodynamics and Pharmacokinetics in Older Men and Postmenopausal Women

Matt S. Anderson, Isaias Noel Gendrano, Chengcheng Liu et al. · The Journal of Clinical Endocrinology & Metabolism · 2013 · 32 citations

, , +14

Prednisone has no effect on the pharmacokinetics of CYP3A4 metabolized drugs – midazolam and odanacatib

Eugene E. Marcantonio, Jeanine Ballard, Christopher R. Gibson et al. · The Journal of Clinical Pharmacology · 2014 · 22 citations

, , +10

Acute and Chronic Effects of Rifampin on Letermovir Suggest Transporter Inhibition and Induction Contribute to Letermovir Pharmacokinetics

Jonathan A. Robbins, Karsten Menzel, Michael E. Lassman et al. · Clinical Pharmacology & Therapeutics · 2021 · 22 citations

, , +17

1–5 of 7